Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.

Nakamura T, Grimer RJ, Gaston CL, Watanuki M, Sudo A, Jeys L.

Bone Joint J. 2013 Mar;95-B(3):411-8. doi: 10.1302/0301-620X.95B3.30344.

PMID:
23450030
2.

Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.

Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A.

Cancer. 2012 Feb 15;118(4):1055-61. doi: 10.1002/cncr.26353. Epub 2011 Jul 14.

3.

The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.

Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A.

Tumour Biol. 2015 Sep;36(10):7515-20. doi: 10.1007/s13277-015-3464-5. Epub 2015 Apr 26.

PMID:
25913621
4.

The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma.

Nakamura T, Grimer R, Gaston C, Francis M, Charman J, Graunt P, Uchida A, Sudo A, Jeys L.

Eur J Cancer. 2013 Jan;49(2):377-85. doi: 10.1016/j.ejca.2012.09.004. Epub 2012 Oct 8.

PMID:
23058786
5.

Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.

Choi ES, Kim HS, Han I.

Ann Surg Oncol. 2014 Mar;21(3):778-85. doi: 10.1245/s10434-013-3418-3. Epub 2013 Dec 4.

PMID:
24306668
6.

Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma.

Funovics PT, Edelhauser G, Funovics MA, Laux C, Berzaczy D, Kubista B, Kotz RI, Dominkus M.

Int Orthop. 2011 Oct;35(10):1529-36. doi: 10.1007/s00264-011-1208-8. Epub 2011 Jan 21.

7.

The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.

Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A.

J Surg Oncol. 2013 Dec;108(7):481-5. doi: 10.1002/jso.23424. Epub 2013 Sep 9.

PMID:
24018883
8.

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.

Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.

J Surg Oncol. 2003 Nov;84(3):151-9.

PMID:
14598359
9.

Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.

Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL.

Cancer. 2003 May 15;97(10):2530-43.

10.

Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution.

Aparicio J, Munárriz B, Pastor M, Vera FJ, Castel V, Aparisi F, Montalar J, Badal MD, Gómez-Codina J, Herranz C.

Oncology. 1998 Jan-Feb;55(1):20-6.

PMID:
9428371
11.

A long-term review of the treatment of patients with Ewing's sarcoma in one institution.

Sluga M, Windhager R, Lang S, Heinzl H, Krepler P, Mittermayer F, Dominkus M, Zoubek A, Kotz R.

Eur J Surg Oncol. 2001 Sep;27(6):569-73.

PMID:
11520091
12.

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.

Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Samonigg H, Maurer-Ertl W, Stojakovic T, Ploner F, Leithner A, Pichler M.

Br J Cancer. 2013 Oct 29;109(9):2316-22. doi: 10.1038/bjc.2013.595. Epub 2013 Oct 1.

13.

The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma.

Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A.

Bone Joint J. 2015 Jun;97-B(6):847-52. doi: 10.1302/0301-620X.97B.35098.

PMID:
26033068
14.

Do pathological fractures influence survival and local recurrence rate in bony sarcomas?

Bramer JA, Abudu AA, Grimer RJ, Carter SR, Tillman RM.

Eur J Cancer. 2007 Sep;43(13):1944-51. Epub 2007 Aug 14.

PMID:
17698347
15.

Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.

Li Y, Liu X, Zhang J, Yao W.

Cancer Biomark. 2016;16(3):333-42. doi: 10.3233/CBM-160571. Review.

PMID:
26835589
16.

Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma.

Nakanishi H, Araki N, Kudawara I, Kuratsu S, Matsumine A, Mano M, Naka N, Myoui A, Ueda T, Yoshikawa H.

Int J Cancer. 2002 May 10;99(2):167-70.

17.

The relationship between pretreatment anaemia and survival in patients with adult soft tissue sarcoma.

Nakamura T, Grimer R, Gaston C, Carter S, Tillman R, Abudu A, Jeys L, Sudo A.

J Orthop Sci. 2013 Nov;18(6):987-93. doi: 10.1007/s00776-013-0454-6. Epub 2013 Aug 14.

PMID:
23943226
18.

C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.

Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.

Urol Oncol. 2013 Nov;31(8):1725-30. doi: 10.1016/j.urolonc.2012.05.008. Epub 2012 Nov 8.

PMID:
23141922
19.

Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.

Jawad MU, Extein J, Min ES, Scully SP.

Clin Orthop Relat Res. 2009 Nov;467(11):2939-48. doi: 10.1007/s11999-009-0749-2. Epub 2009 Feb 18.

20.

Supplemental Content

Support Center